SEC Form 4 · accession 0001140361-15-011707
SALIX PHARMACEUTICALS LTD · SLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P Keane
Director
Period of report
Mar 9, 2015
Accepted (ET)
Mar 13, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001009356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2015 | G | 600 | $0.00 | D | 39,160 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Buy Common StockF1 | $17.63 | holding | — | — | — | — | Jun 9, 2015 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Options are 100% vested.